Brief: Vaccibody: Promising Preclinical Data With COVID-19 Vaccine Candidate In Mice
Dec 10 (Reuters) - Vaccibody AS VACC-ME.OL :
* REPORTS PROMISING PRECLINICAL DATA WITH A
SECOND-GENERATION
COVID-19 VACCINE AND ANNOUNCES ITS INFECTIOUS DISEASE STRATEGY
* PROMISING PRE-CLINICAL DATA WITH ITS COVID-19 VACCINE
CANDIDATE,
VB10.COV2, IN MICE
Source text for Eikon: ID:nObiymPzTa
Further company coverage: VACC-ME.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026